Suzhou Ribo Life Science Co.
Latest round
- Series E
Last raised
- Jul 2025
Total raised
- $222M
Investors
- 25
About Suzhou Ribo Life Science Co.
, Ltd. is a biopharmaceutical engaged in the research and development of RNAi technologies and oligonucleotide therapeutics. In August 2020, the company received the approval of clinical trials for new drug treatment of metastatic prostate cancer. In February 2022, it established an international R&D center in Gothenburg, Sweden., Ltd. was converted into a joint stock company.97 apiece on the Hong Kong Exchanges and Clearing (HKEX) under the ticker "6938"., Ltd. specializes in developing oligonucleotide drugs based on RNA interference (RNAi) technology, focusing on cardiovascular, metabolic, renal and liver diseases, as well as other therapeutic areas. The company's core products include RBD4059, an siRNA (small interfering RNA) drug that targets thrombotic diseases; RBD1016, an siRNA drug for patients with chronic hepatitis B Virus (“HBV”) infection, and other drug candidates for hereditary angioedema and inflammatory diseases. The company generates revenue from developing and commercializing oligonucleotide drugs globally.
Who invested in Suzhou Ribo Life Science Co.
25 investors across 7 rounds
See all investors in Suzhou Ribo Life Science Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Jul 21, 2025
Amount
$28M
Investors
Series E
Jul 29, 2022
Amount
$40M
Investors
Series C
Apr 3, 2020
Amount
$66M
Investors
Series C
Dec 5, 2019
Amount
$29M
Investors
Series B
Dec 1, 2017
Amount
Undisclosed
Investors
Series B
Mar 17, 2017
Amount
$39M
Investors
Series A
Sep 28, 2015
Amount
$20M
Investors
Questions about Suzhou Ribo Life Science Co.
Who invested in Suzhou Ribo Life Science Co.?
Suzhou Ribo Life Science Co. has 25 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Suzhou Ribo Life Science Co. raised?
Suzhou Ribo Life Science Co. has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Suzhou Ribo Life Science Co. last raise money?
Suzhou Ribo Life Science Co.'s most recent round on record is a Series E, in Jul 2025.
What does Suzhou Ribo Life Science Co. do?
Suzhou Ribo Life Science Co. is a pharmaceuticals company.
Where is Suzhou Ribo Life Science Co. headquartered?
Suzhou Ribo Life Science Co. is headquartered in Suzhou, China.
Which VCs invest in companies like Suzhou Ribo Life Science Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Suzhou Ribo Life Science Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Suzhou Ribo Life Science Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.